Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-24 @ 5:14 PM
NCT ID:
NCT00521950
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older
* Diagnosis of a form of IBD
* Indication for azathioprine/6-MP treatment
* Patient giving (written) informed consent
Exclusion Criteria:
* Previous treatment with azathioprine/6-MP
* Co-prescription of allopurinol (this treatment blocks xanthine oxidase, an enzyme important for thiopurine metabolism)
* Baseline leukocyte count less then 3x10\^9 per litre
* Reduced liver function at baseline
* Reduced renal function at baseline
* Known TPMT phenotype (enzyme activity / Therapeutic Drug Monitoring) or genotype
* Pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00521950
Study Brief:
Protocol Section:
NCT00521950